Gastric bypass for morbid obesity in patients 50 years or older

Is laparoscopic technique safer?

Rodrigo Gonzalez, Edward Lin, Samer Mattar, Kota R. Venkatesh, C. Daniel Smith

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Some physicians have considered age ≥50 years as a relative contraindication for bariatric surgery. Recent reports demonstrated the safety and efficacy of Roux-en-Y gastric bypass (RYGB) in this patient subgroup, but comparisons between laparoscopic technique (LT) and open technique (OT) have not been reported. A review of 52 patients ≥50 years old who underwent RYGB between January 1999 and April 2002 was conducted. Demographics, operative data, and outcomes were assessed. Preoperative and postoperative renal and hepatic functions, electrolytes, anemia studies, and hematology results were compared. Patients were divided into LT and OT groups and operative outcomes were compared. The percentage of excess body weight loss was 66 ± 4 per cent at mean follow-up of 12 months. Blood samples drawn after a mean of 8 ± 2 months revealed no postoperative metabolic alterations. RYGB resulted in a reduction of the number of patients with hyperglycemia, hypertension, degenerative joint disease, gastroesophageal reflux disease, and continuous positive airway pressure-dependent sleep apnea (P <0.05). The LT resulted in fewer intensive care unit admissions and shorter length of stay. RYGB is safe and well tolerated in patients ≥50 years resulting in no renal, hepatic, or electrolytic alterations. Weight loss and control of obesity-related comorbidities are satisfactory. The LT results in fewer intensive care unit admissions and shorter length of stay than the OT.

Original languageEnglish (US)
Pages (from-to)547-553
Number of pages7
JournalAmerican Surgeon
Volume69
Issue number7
StatePublished - 2003
Externally publishedYes

Fingerprint

Gastric Bypass
Morbid Obesity
Intensive Care Units
Weight Loss
Length of Stay
Kidney
Continuous Positive Airway Pressure
Bariatric Surgery
Liver
Sleep Apnea Syndromes
Hematology
Gastroesophageal Reflux
Osteoarthritis
Hyperglycemia
Electrolytes
Comorbidity
Anemia
Obesity
Body Weight
Demography

ASJC Scopus subject areas

  • Surgery

Cite this

Gonzalez, R., Lin, E., Mattar, S., Venkatesh, K. R., & Smith, C. D. (2003). Gastric bypass for morbid obesity in patients 50 years or older: Is laparoscopic technique safer? American Surgeon, 69(7), 547-553.

Gastric bypass for morbid obesity in patients 50 years or older : Is laparoscopic technique safer? / Gonzalez, Rodrigo; Lin, Edward; Mattar, Samer; Venkatesh, Kota R.; Smith, C. Daniel.

In: American Surgeon, Vol. 69, No. 7, 2003, p. 547-553.

Research output: Contribution to journalArticle

Gonzalez, R, Lin, E, Mattar, S, Venkatesh, KR & Smith, CD 2003, 'Gastric bypass for morbid obesity in patients 50 years or older: Is laparoscopic technique safer?', American Surgeon, vol. 69, no. 7, pp. 547-553.
Gonzalez, Rodrigo ; Lin, Edward ; Mattar, Samer ; Venkatesh, Kota R. ; Smith, C. Daniel. / Gastric bypass for morbid obesity in patients 50 years or older : Is laparoscopic technique safer?. In: American Surgeon. 2003 ; Vol. 69, No. 7. pp. 547-553.
@article{abdc6a8b11884ef89cf6556f3da068d9,
title = "Gastric bypass for morbid obesity in patients 50 years or older: Is laparoscopic technique safer?",
abstract = "Some physicians have considered age ≥50 years as a relative contraindication for bariatric surgery. Recent reports demonstrated the safety and efficacy of Roux-en-Y gastric bypass (RYGB) in this patient subgroup, but comparisons between laparoscopic technique (LT) and open technique (OT) have not been reported. A review of 52 patients ≥50 years old who underwent RYGB between January 1999 and April 2002 was conducted. Demographics, operative data, and outcomes were assessed. Preoperative and postoperative renal and hepatic functions, electrolytes, anemia studies, and hematology results were compared. Patients were divided into LT and OT groups and operative outcomes were compared. The percentage of excess body weight loss was 66 ± 4 per cent at mean follow-up of 12 months. Blood samples drawn after a mean of 8 ± 2 months revealed no postoperative metabolic alterations. RYGB resulted in a reduction of the number of patients with hyperglycemia, hypertension, degenerative joint disease, gastroesophageal reflux disease, and continuous positive airway pressure-dependent sleep apnea (P <0.05). The LT resulted in fewer intensive care unit admissions and shorter length of stay. RYGB is safe and well tolerated in patients ≥50 years resulting in no renal, hepatic, or electrolytic alterations. Weight loss and control of obesity-related comorbidities are satisfactory. The LT results in fewer intensive care unit admissions and shorter length of stay than the OT.",
author = "Rodrigo Gonzalez and Edward Lin and Samer Mattar and Venkatesh, {Kota R.} and Smith, {C. Daniel}",
year = "2003",
language = "English (US)",
volume = "69",
pages = "547--553",
journal = "The American surgeon",
issn = "0003-1348",
publisher = "Southeastern Surgical Congress",
number = "7",

}

TY - JOUR

T1 - Gastric bypass for morbid obesity in patients 50 years or older

T2 - Is laparoscopic technique safer?

AU - Gonzalez, Rodrigo

AU - Lin, Edward

AU - Mattar, Samer

AU - Venkatesh, Kota R.

AU - Smith, C. Daniel

PY - 2003

Y1 - 2003

N2 - Some physicians have considered age ≥50 years as a relative contraindication for bariatric surgery. Recent reports demonstrated the safety and efficacy of Roux-en-Y gastric bypass (RYGB) in this patient subgroup, but comparisons between laparoscopic technique (LT) and open technique (OT) have not been reported. A review of 52 patients ≥50 years old who underwent RYGB between January 1999 and April 2002 was conducted. Demographics, operative data, and outcomes were assessed. Preoperative and postoperative renal and hepatic functions, electrolytes, anemia studies, and hematology results were compared. Patients were divided into LT and OT groups and operative outcomes were compared. The percentage of excess body weight loss was 66 ± 4 per cent at mean follow-up of 12 months. Blood samples drawn after a mean of 8 ± 2 months revealed no postoperative metabolic alterations. RYGB resulted in a reduction of the number of patients with hyperglycemia, hypertension, degenerative joint disease, gastroesophageal reflux disease, and continuous positive airway pressure-dependent sleep apnea (P <0.05). The LT resulted in fewer intensive care unit admissions and shorter length of stay. RYGB is safe and well tolerated in patients ≥50 years resulting in no renal, hepatic, or electrolytic alterations. Weight loss and control of obesity-related comorbidities are satisfactory. The LT results in fewer intensive care unit admissions and shorter length of stay than the OT.

AB - Some physicians have considered age ≥50 years as a relative contraindication for bariatric surgery. Recent reports demonstrated the safety and efficacy of Roux-en-Y gastric bypass (RYGB) in this patient subgroup, but comparisons between laparoscopic technique (LT) and open technique (OT) have not been reported. A review of 52 patients ≥50 years old who underwent RYGB between January 1999 and April 2002 was conducted. Demographics, operative data, and outcomes were assessed. Preoperative and postoperative renal and hepatic functions, electrolytes, anemia studies, and hematology results were compared. Patients were divided into LT and OT groups and operative outcomes were compared. The percentage of excess body weight loss was 66 ± 4 per cent at mean follow-up of 12 months. Blood samples drawn after a mean of 8 ± 2 months revealed no postoperative metabolic alterations. RYGB resulted in a reduction of the number of patients with hyperglycemia, hypertension, degenerative joint disease, gastroesophageal reflux disease, and continuous positive airway pressure-dependent sleep apnea (P <0.05). The LT resulted in fewer intensive care unit admissions and shorter length of stay. RYGB is safe and well tolerated in patients ≥50 years resulting in no renal, hepatic, or electrolytic alterations. Weight loss and control of obesity-related comorbidities are satisfactory. The LT results in fewer intensive care unit admissions and shorter length of stay than the OT.

UR - http://www.scopus.com/inward/record.url?scp=0041701407&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0041701407&partnerID=8YFLogxK

M3 - Article

VL - 69

SP - 547

EP - 553

JO - The American surgeon

JF - The American surgeon

SN - 0003-1348

IS - 7

ER -